tm logo

Monitor this mark

View On USPTO

INFECTIMUNE
Live/Registered
REGISTERED

on 01 Aug 2023

Last Applicant/ Owned by

PDS Biotechnology Corporation

25B Vreeland Road, Suite 300

Florham Park

NJ

07932

Serial Number

97137823 filed on 22nd Nov 2021

Registration Number

7128358 registered on 01st Aug 2023

in the Principal Register

Correspondent Address

Michael A. Geller

Michael A. Geller

P.O. BOX 64807

CHICAGO, IL 60664-0807

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

INFECTIMUNE

Pharmaceutical research services, namely, the use of cationic lipid nanotechnology to stimulate immune responses for the purpose of identifying and developing pharmaceutical candidates

Classification Information

Class [042]
Computer & Software Services & Scientific Services

Pharmaceutical research services, namely, the use of cationic lipid nanotechnology to stimulate immune responses for the purpose of identifying and developing pharmaceutical candidates

First Use Date in General

19th Dec 2021

First Use Date in Commerce

19th Dec 2021

Mark Details

Serial Number

No 97137823

Mark Type

No Service Mark

Attorney Docket Number

No 392227-1

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
01st Aug 2023REGISTERED-PRINCIPAL REGISTER
01st Aug 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
30th Jun 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
29th Jun 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07th Jun 2023STATEMENT OF USE PROCESSING COMPLETE
05th Jun 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
11th May 2023TEAS STATEMENT OF USE RECEIVED
11th May 2023USE AMENDMENT FILED
13th Dec 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
18th Oct 2022PUBLISHED FOR OPPOSITION